The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models-Reference-Cited by-同舟云学术

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

Published:2016-10 Issue:7626 Volume:538 Page:477-482
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Kotschy András,Szlavik Zoltán,Murray James,Davidson James,Maragno Ana Leticia,Le Toumelin-Braizat Gaëtane,Chanrion Maïa,Kelly Gemma L.,Gong Jia-Nan,Moujalled Donia M.,Bruno Alain,Csekei Márton,Paczal Attila,Szabo Zoltán B.,Sipos Szabolcs,Radics Gábor,Proszenyak Agnes,Balint Balázs,Ondi Levente,Blasko Gábor,Robertson Alan,Surgenor Allan,Dokurno Pawel,Chen Ijen,Matassova Natalia,Smith Julia,Pedder Christopher,Graham Christopher,Studeny Aurélie,Lysiak-Auvity Gaëlle,Girard Anne-Marie,Gravé Fabienne,Segal David,Riffkin Chris D.,Pomilio Giovanna,Galbraith Laura C. A.,Aubrey Brandon J.,Brennan Margs S.,Herold Marco J.,Chang Catherine,Guasconi Ghislaine,Cauquil Nicolas,Melchiore Fabien,Guigal-Stephan Nolwen,Lockhart Brian,Colland Frédéric,Hickman John A.,Roberts Andrew W.,Huang David C. S.,Wei Andrew H.,Strasser Andreas,Lessene Guillaume,Geneste Olivier

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature19830.pdf

Reference51 articles.

1. Green, D. R. & Llambi, F. Cell death signaling. Cold Spring Harb. Perspect. Biol. 7, 1–24 (2015)

2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)

3. Czabotar, P. E., Lessene, G., Strasser, A. & Adams, J. M. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63 (2014)

4. Petros, A. M. et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9, 2528–2534 (2000)

5. Delbridge, A. R. D., Grabow, S., Strasser, A. & Vaux, D. L. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat. Rev. Cancer 16, 99–109 (2016)

Cited by 791 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer;Frontiers in Oncology;2024-02-02

2. Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen;Journal of Medicinal Chemistry;2024-02-02

3. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms;European Journal of Medicinal Chemistry;2024-02

4. Melatonin sensitizes leukemia cells to the MCL1 inhibitors S63845 and A‐1210477 through multiple pathways;Journal of Pineal Research;2024-01-31

5. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate;Biomolecules;2024-01-22